This Healthcare company, which deals in the business of healthcare service providers that operates in GCC countries and in India, is in focus after the promoters reduced pledge to 41 percent.
Price Movement
Aster DM Healthcare Limited‘s stock in Thursday’s session touched a day’s high of Rs. 437 which is up by 1.02 percent. The stock reiterated from the day’s high and was trading at Rs. 433.55, which is 0.23 percent higher than the previous closing price of Rs. 432.55.
The stock has delivered a return of around 5 percent in the past year and performed on par with the Nifty Index in the same period.
What Happened
The company’s stock is in focus after Aster DM Healthcare’s promoters released their pledge from earlier 99 percent to 41 percent after completion of debt refinancing transactions from global financial institutions such as JP Morgan, HSBC & Barclays which has provided fresh funding to the which promoters were able to refinance through better terms as well as loan to value as per sources.
Further, Founder & Chairman of Aster DM Healthcare said “ The reduction in Aster’s pledged shares is a significant testament to our financial strength as promoters, especially in light of the volatile global market conditions.”
Promoters Plans to cut stake & Guidance
Alisha Moopen said in an interview, as per sources, that the goal is to further reduce the pledge in the next 12 to 18 months. The Merger benefits will start by early FY26. The margins are expected in the range of 25 percent in the upcoming 3 to 5 years. The Revenue growth is expected in the high teens in the next 2 to 3 years. Further, she said that promoters will not be selling their stake.
Business Segments
As of the December 2024 quarter, Aster DM Healthcare recognised 95.40 percent of its operational revenue from Hospitals, followed by 0.91 percent from Clinics, 3.48 percent from Wholesale Pharmacies, and the remaining 0.19 percent from Others.
Financial Performance
Their Q3FY25 results show revenue from operations of Rs. 1,050 crore which declined by 9.94 percent year on year, from Rs. 955 crore in Q3FY24. Their net profit declined by 69.37 percent year on year, from Rs. 209 crores in Q3FY24 to Rs. 64 crores in Q3FY25.
Company Overview
Aster DM Healthcare, founded by Dr. Azad Moopen in 1987, is a multinational healthcare network headquartered in Dubai and registered in Bengaluru. Operating across nine countries, it manages hospitals, clinics, pharmacies, and diagnostic centers under brands like Aster, Medcare, and Access, with 19,800+ employees delivering patient-centric care.
Written by Santhosh S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
